Corona: What measures have Governments taken in the Life Sciences Sector?
Recommendation
7/8 May 2024
How to foster Continual Quality Improvement
Register now for ECA's GMP Newsletter
Governments have been implementing different emergency measures in the fight against the current pandemic. The Baker McKenzie Healthcare and Life Sciences Industry Group has now published an interesting overview of the different measures that various governments across the EMEA region (Europe, Middle East, Asia) have adopted in the area of healthcare and life sciences in response to the COVID-19 outbreak.
In this document, Baker McKenzie lawyers across EMEA share their high-level views on the following areas:
- Requisition powers
- Price and reimbursement
- Public procurement
- Legal deadlines
- Relaxation of regulatory rules
Related GMP News
21/02/2024
GMP Conferences by Topics
- General Quality Assurance and GMP Compliance Topics
- Hygiene
- General Microbiology Topics
- Regulatory Affairs
- Development
- General Analytics Topics
- Good Distribution Practice
- Sterile Manufacturing
- Computer Validation
- General Qualification/Validation Topics
- General Engineering Topics
- APIs/Excipients
- GMP Basic Training Courses
- Medical Devices and Combination Products
- Packaging and Packaging Material
- Data Integrity
- Qualified Person (QP)
- GMP Auditing
- Documentation
- Cleaning Validation
- General IT Compliance Topics
- Impurities
- OOS / OOE / OOT
- Material Testing
- Validation of Analytical Methods
- Analytical Instrument Qualification
- Stability Testing
- Microbiological Testing
- Technology
- General Manufacturing Topics
- Solid Dosage Forms/Semi-Solid Dosage Forms
- Biotechnology/Blood/ATMP
- Herbal Drug Products/Cannabis/Radiopharmaceuticals
- Others